CN Stock MarketDetailed Quotes

002898 Sailong Pharmaceutical Group

Watchlist
  • 9.44
  • +0.86+10.02%
Trading Sep 9 13:48 CST
1.66BMarket Cap200.85P/E (TTM)

About Sailong Pharmaceutical Group Company

The company was founded in 2002 and is a high-tech enterprise integrating R&D, production and sales of pharmaceuticals. Currently, its products are mainly concentrated in the fields of nervous system, cardiovascular system and digestive system. The company is a pharmaceutical enterprise in the entire pharmaceutical industry chain integrating R&D, production, marketing and technical services of pharmaceutical intermediates, APIs, and formulations. The company's main products include injectable tigacycline and APIs, agatracycline injections and APIs, esomeprazole sodium and APIs, aspartate ornithine injections and APIs, milinone injections and APIs, injectable parecoxib sodium and APIs, tranexamic acid injections and APIs, injectable brain protein hydrolysates (III), injectable thymus fasin, injectable pantoprazole sodium, and pregabalin capsules and APIs, asapipran tablets and raw materials, etc.

Company Profile

Short Name-A赛隆药业
Symbol-A002898
Company NameSailong Pharmaceutical Group Co.,Ltd.
Listing DateSep 12, 2017
Issue Price8.31
Shares Offered40.00M share(s)
FoundedApr 3, 2002
Listed ExchangeSZ Stock Exchange
Legal Representativenangui cai
General Managernangui cai
Secretaryxu zhang
Accounting FirmGrant Tung Certified Public Accountants (Special General Partnership)
Securities Representativehaiyan tan
Legal CounselBeijing Kangda Law Firm
Employees23
Phone0756-3882955
Office Address21st Floor, Unit 2, No. 31 Nanwan North Road, Xiangzhou District, Zhuhai, Guangdong
Zip Code519060
Registered Address21st Floor, Unit 2, No. 31 Nanwan North Road, Xiangzhou District, Zhuhai, Guangdong
Fax0756-3352738
Emailir@sl-pharm.com
Websitehttp://www.sailong.cn/
Business License440400000086623
BusinessLicense items: pharmaceutical production; pharmaceutical wholesale; food production; production of formula food for special medical purposes; production of health food; production of class II medical devices; production of class III medical devices; business of class III medical devices; food sales; import and export of pharmaceuticals; sales of pharmaceutical excipients. (Projects requiring approval according to law can only be carried out after approval by relevant departments; specific business projects are subject to documents or licenses approved by relevant departments) General projects: medical research and experimental development; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; food sales (sales of pre-packaged foods only); sales of formula foods for special medical purposes; sales of health food (pre-packaged); production of class I medical devices; sales of class I medical devices; sales of class II medical devices; sales of specialty chemical products (excluding hazardous chemicals); import and export of goods; Technology import and export; domestic trade agency; cosmetics wholesale; chemical product sales (excluding licensed chemical products); marketing planning; information consulting services (excluding licensing information consulting services); market research (excluding foreign-related surveys); housing leasing; non-residential real estate leasing; machinery and equipment leasing. (With the exception of projects subject to approval according to law, independently carry out business activities based on a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • nangui cai
  • Chairman, Directors, President, Chairman of the Strategic Decision Committee
  • 511.40K
  • dawen liu
  • Directors, Executive Vice President, Nomination Committee Members, Member of the Strategic Decision Committee, Member of the Remuneration and Assessment Committee
  • 568.60K
  • lin tang
  • Directors, Audit Committee Member, Member of the Strategic Decision Committee
  • 401.80K
  • xu zhang
  • Directors, Board Secretary, Deputy General Manager, Member of the Strategic Decision Committee
  • 483.00K
  • jianfeng li
  • Directors, Deputy General Manager, Member of the Strategic Decision Committee
  • 445.30K
  • yongjun deng
  • Directors, Member of the Strategic Decision Committee
  • 403.10K
  • gongfen li
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 100.00K
  • chuanyun pan
  • Independent Directors, Chairman of the Audit Committee, Nomination Committee Members
  • 120.00K
  • xiaoxin chen
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • 120.00K
  • haiyan tan
  • Securities Affairs Representative
  • --
  • zhixiang long
  • Chairman of the Supervisory Board, Auditors
  • 359.20K
  • bei zhou
  • Auditors
  • 355.10K
  • daifeng duan
  • VP
  • --
  • xing wang
  • Deputy General Manager
  • 524.50K
  • jing gao
  • Chief Financial Officer
  • 370.30K
  • xingyan luo
  • Head of Internal Audit
  • --
  • haibo huang
  • Employee Supervisors
  • 320.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg